CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveThe 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responsesComplex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein.Personalized therapy for metastatic melanoma: could timing be everything?Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlationsComplete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma.Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertilityImmunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy.Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions.Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.Cytokines in radiobiological responses: a review.High-sensitivity C-reactive protein and cancer.Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.Dendritic cell therapy for oncology roundtable conference.In silico tumor control induced via alternating immunostimulating and immunosuppressive phases.Immune monitoring using the predictive power of immune profilesMulberry leaf reduces oxidation and C-reactive protein level in patients with mild dyslipidemia.C-reactive Protein and Disease Outcome in Nigerian Sickle Cell Disease Patients.Diet Quality, Inflammation, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Analysis of Pilot Study Data.Dose selection of siltuximab for multicentric Castleman's disease.Oxidative stress and insulin resistance in policemen working shifts.Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications.On detection of periodicity in C-reactive protein (CRP) levels
P2860
Q24594814-8193DFB7-F375-4384-9008-B12AABA3D8FFQ24616434-8043ACC2-4CF0-4C95-ABFE-257CF8F5C297Q33417707-E0840B54-7202-47DD-8FCF-7DDCC851E16DQ33576035-ACBF5C35-5EB4-48CD-9198-E447E6FEFC05Q33848273-722C9D0D-50F0-4D21-9DB3-F4DB1A144D32Q34032559-C0F8960D-A501-4719-9661-6F52E69FD469Q34407541-105A98BB-721A-4FC7-AFC7-33E46867DA61Q34534663-25CFFAB9-BD7C-4A3D-826B-4A9B93DD5D49Q34553859-750782C8-2EBD-4545-A661-D942657925A0Q34855293-4BCB0E08-AF32-4991-91DC-012E88EF6D3FQ36213487-11FFFDCB-83A8-4A2C-8425-5FA4929781E3Q36389628-77860909-F994-44D9-8CC7-301A88351CE7Q36444444-25FE275A-3601-4B8E-82C3-A3F372DB934FQ37045283-1963A6E6-12A7-41A1-B453-48A8B2FA158DQ37506191-6757E796-CA37-42F5-A32D-9D0958F2AF51Q37649049-235F12FD-C768-4A76-9DE6-07DF03C57188Q39794478-57D96DA5-8D93-4BEC-8C60-5A9FB89C0DF1Q41364263-416B1FE7-A82F-4626-A9C1-7E7C63EB12F3Q41684399-BB566E61-F592-4336-B345-62BB4CAB3619Q42044031-2306C3A8-A0F0-43BA-9D89-374938360299Q42093646-EE4E3480-EBD0-4FA4-BA2A-FBEFAA4A136AQ47322057-3D3FA2EB-02E8-4912-A02B-D355D259A6D1Q53574282-F4E660DC-5E8E-443B-84A6-EA34714F44D3Q53829403-A4A4D2AE-EE6C-4E82-823F-F6D89D789F91Q54100256-8F39D45D-D76E-452B-934B-B3E00842CDF0Q57169992-9315CB3B-BF9E-4A87-8A75-9C06CA4AC380
P2860
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@ast
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@en
type
label
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@ast
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@en
prefLabel
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@ast
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@en
P2093
P2860
P921
P356
P1476
CRP identifies homeostatic imm ...... tial treatment targeting tool?
@en
P2093
Brendon J Coventry
Martin L Ashdown
Steven L Yatomi-Clarke
Svetomir N Markovic
P2860
P2888
P356
10.1186/1479-5876-7-102
P5008
P577
2009-11-30T00:00:00Z
P5875
P6179
1008508784